摘要
目的探讨早期诊断糖尿病肾病的方法。方法用酶联免疫吸附试验法检测尿中视黄醇结合蛋白(RBP)和Ⅳ型胶原(Ⅳ-C),免疫发光法检测尿微量清蛋白(mAlb)及转铁蛋白(TF),终点法测N-乙酰-β-D氨基葡萄糖苷酸酶(NAG),Jaffe法测定尿肌酐(Cr)。结果健康对照组中尿TF/Cr为(1.10±0.76)mg/mmol、mAlb/Cr为(1.50±0.81)mg/mmol、NAG/Cr为(5.65±2.40)U/g、RBP/Cr为(2.15±0.93)mg/mmol及Ⅳ-C的含量为(44.68±17.2)ng/mL。在糖尿病无肾病组中,其mAlb的含量与健康对照组相近,差异无统计学意义(P>0.05);而NAG、RBP、TF及Ⅳ-C的含量与健康对照组相比,差异有统计学意义(P<0.05)。在糖尿病的初期肾病组和临床肾病组,mAlb/Cr、NAG/Cr、RBP/Cr、TF/Cr及Ⅳ-C的含量均明显高于健康对照组,差异有统计学意义(P<0.01)。结论联合检测尿NAG、RBP、TF及Ⅳ-C是诊断糖尿病肾病早期损伤灵敏、可靠的实验室指标。
Objective To explore a method for early diagnosis of diabetic nephropathy. Methods ELISA was applied to detecting urine retinol binding protein (RBP) and type Ⅳ collagen (Ⅳ-C), immunolumineseence assay measuring urinary mieroalbuminn (mAlb) and transferring (TF) ,endpoint method determining urinary N-acetyl-β-D- glucosaminidase (NAG) ,and Jaffe's method measuring urinary creatinine (Cr). Results The levels of urinary TF/ Cr,mAlb/Cr,NAG/Cr,RBP/Cr and Ⅳ-C in healthy control group were (1.10±0.76)mg/mmol,(1.50±0.81)rag/ mmol, ( 5.65 ± 2.40) U/g, (2.15 ± 0.93) rag/retool and (44.68 ± 7.2) ng/mL. In the group of diabetes mellitus without nephropathy,the level of mAlb was approximate to that of healthy control group (P〉0. 05) ,whereas the levels of urinary NAG,RBP,TF and Ⅳ-C were significantly higher (P〈0. 05). The levels of urinary TF/Cr, mAlb/Cr, NAG/Cr,RBP/Cr and Ⅳ-C in the groups of diabetic nephropathy (initial stage group and clinical nephropathy group) than those in healthy control group (P〈0. 01). Conclusion Combined detection of NAG,RBP,TF and Ⅳ-c is a sensitive and reliable laboratory indicator of early diagnosis of diabetic nephropathy.
出处
《检验医学与临床》
CAS
2009年第1期19-20,22,共3页
Laboratory Medicine and Clinic